References
- Connock M, Juarez-Garzia A, Jowett S, Frew E, Liu Z, Taylor RJ, . Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Tecnol Assess 2007;11:1–171.
- Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2008, Issue 2. Art. No.: CD002207. DOI: 10.1002/14651858.CD002207.pub3.
- Alho H, Sinclair D, Vuori E, Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 2007a;88:75–8.
- Alho H, Vuori E, Holopainen A. Laittomasta opiaattikorvaushoidosta päästävä laillisen hoidon piiriin. [From illegal opiate use to maintenance treatment]. In Finnish. Duodecim 2007b;123:757–59.
- Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviours of needle exchange program attenders. AIDS Educ Prev 2003:15;257–68.
- Stolz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health 2007;29:35–9.
- McLellan AT, Luborsky L, Woody GE, O'Brian CP. An improved diagnostic evaluation instrument of substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis 1980;168:26–33.
- Blanken P, Hendriks V, Pozzi G, Tempesta E, Hartgers C, Koeter M, . European Addiction Severity Index (EuropASI). A guide to training and administering EuropASI interviews. 1994, Evaluation Instrument Bank.
- Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90;607–14.
- Hodgins DC, El-Guebaly N. More data on the Addiction Severity Index. Reliability and validity with mentally ill substance abusers. J Nerv Ment Dis 1992;180:197–201.
- Leonhard CL, Mulvey K, Gastfriend DR, Schwartz M. The Addiction Severity Index: A field study of internal consistency and validity. J Subst Abuse Treat 2000;18:129–35.
- Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psych Rev 1988;8:77–100.
- Lykke J, Hesse M, Austin SF, Oestrich I. Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addict Behav 2008;33:292–300.
- Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Gölz J, . Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients. Drug Alcohol Depend 2008;95;245–57.
- Soeffing JM, Martin LD, Fingerhood MI, Jasinski DR, Rastegar DA. Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year. J Subs Abuse Med 2009;37:426–30.
- Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med 2009;24:226–32.
- Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. Br J Gen Pract 2005;55:139–46.
- Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008;103:462–8.
- Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug Alcohol Depend 2009;105:9–15.
- Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction 2009;104:1193–200.
- Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug Alcohol Depend 2008;94:151–7.